about
Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosisVaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.Revaccination of cattle with bacille Calmette-Guérin two years after first vaccination when immunity has waned, boosted protection against challenge with Mycobacterium bovis.Control of Mycobacterium bovis infections and the risk to human populations.New skin test for detection of bovine tuberculosis on the basis of antigen-displaying polyester inclusions produced by recombinant Escherichia coli.Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens.Diverse cytokine profile from mesenteric lymph node cells of cull cows severely affected with Johne's disease.A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.Cattle as a model for development of vaccines against human tuberculosis.Enhancement of the sensitivity of the whole-blood gamma interferon assay for diagnosis of Mycobacterium bovis infections in cattle.Progress in the development of tuberculosis vaccines for cattle and wildlife.Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.Vaccines against bovine mastitis in the New Zealand context: what is the best way forward?Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity.Update on vaccination of cattle and wildlife populations against tuberculosis.Progress in the development of vaccines against rumen methanogens.Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans.Autoimmune Addison's disease. Analysis of autoantibody binding sites on human steroid 21-hydroxylase.Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.Vaccination of cattle with a high dose of BCG vaccine 3 weeks after experimental infection with Mycobacterium bovis increased the inflammatory response, but not tuberculous pathology.Display of Antigens on Polyester Inclusions Lowers the Antigen Concentration Required for a Bovine Tuberculosis Skin TestComparison of gene expression of immune mediators in lung and pulmonary lymph node granulomas from cattle experimentally infected with Mycobacterium bovis.Development of a vaccine to mitigate greenhouse gas emissions in agriculture: vaccination of sheep with methanogen fractions induces antibodies that block methane production in vitro.Molecular cloning and physiological effects of brushtail possum interleukin-1beta.Dairy cows produce cytokine and cytotoxic T cell responses following vaccination with an antigenic fraction from Streptococcus uberis.Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins.Vaccination of cattle with a methanogen protein produces specific antibodies in the saliva which are stable in the rumen.Streptococcus uberis-specific T cells are present in mammary gland secretions of cows and can be activated to kill S. uberis.Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccines.Altered patterns of toll-like receptor gene expression in cull cows infected with Mycobacterium avium subsp. paratuberculosis.Autoimmune Addison's disease and 21-hydroxylaseSteroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's diseaseNaturally occurring mutations in human steroid 21-hydroxylase influence adrenal autoantibody bindingAdrenal autoantibodies and naturally occurring mutations in 21-hydroxylaseAutoimmune Addison's disease--evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiencyAntigen-induced interferon-gamma and interleukin-2 responses of cattle inoculated with Mycobacterium bovisIn vitro control of Mycobacterium bovis by macrophagesNew generation vaccines and delivery systems for control of bovine tuberculosis in cattle and wildlifeMucosal immunity in the brushtail possum (Trichosurus vulpecula): detection of antibody in serum and at female reproductive sites after intranasal immunization
P50
Q33592353-8400FFFC-085C-4CF4-87D0-04D1C4717B88Q33788201-74117D1F-27E9-4728-A125-AF965CC4404AQ33883504-768417FA-F510-4F2A-B4ED-8E789718A587Q34122572-40285985-17FE-4E29-8F2D-0D0CBB83FFE8Q34587098-839EC2AB-FB4A-4354-B33E-9D12D109F2DEQ35095115-2C688973-D7D0-4E75-9838-63B6A131B389Q35143282-77547515-A621-4A69-A780-6D13D434CFCFQ35191190-5572913E-7D3C-4482-AB47-D3DE049ED366Q35801915-61297176-2967-47DE-B8F0-14E6F5B40F2CQ36027515-C86BA328-ADCB-43A3-838B-2CE041C663C5Q36313607-44EA38E0-4B5D-40A8-8816-CBB9BC15A6C4Q36330400-4922CE16-1E46-4911-95CD-7DB58EF0DA78Q37477387-94EE4AF2-C08F-4BA7-B41B-950CD62ACE32Q37517207-5B5688D4-B241-41D2-894B-95A17C5FBCDFQ37620529-34C8FF40-FC0C-460F-BD76-67771E51E0E2Q37855175-BCE227BD-E896-455C-A78D-5974ED736C2DQ38112279-8B1A3DEC-E695-4867-A134-156D84328EDAQ38156497-F4F01AA8-9E69-439B-9FFF-3F2DCD498D77Q38315258-E7001B29-0E15-4293-9ACC-9A959F295CE7Q39982362-F18353BF-D78C-47E1-82BF-FECBF2A6BB2DQ40602534-CE22D478-171A-4BF1-AF74-B72387E2CB5DQ40933335-6941E6DD-1B72-4402-A88F-030DCB7B17B7Q42214292-83BDD173-E24A-473F-B547-9479908E4B91Q42468143-ED06F477-6CC8-4D85-B88D-B58C3CCB1820Q42599455-72FF7325-B7C5-4372-80E4-AF631AEA0A91Q43595244-577B7363-1C0E-49D1-8762-29F49DE4763DQ43953974-FC522A6A-7FC4-4DCB-B9B4-FD592343FA8AQ50998153-4147394A-4BCD-4E96-8AE0-845ACA229773Q51021566-FCF03399-7CDA-413B-9544-0E5C60EA3722Q51378356-64C2E7D3-7170-4300-A06A-DF826E282386Q54339657-0C09FAB5-7219-463B-8903-E9BF0ED0845BQ67519306-F302F254-B3A6-4909-BFB5-9AB848193598Q68026906-7224564E-948D-4730-9C99-5D6C3BB12089Q72095093-B92CCDB8-0559-4617-86CF-FCD0A5739F43Q72775527-BE9C31AB-E3F5-41FA-9A7F-7CD21DA100FFQ72810179-34490EAD-E39E-489B-A5F7-17B4321AE787Q73549816-017D4AFB-087E-45EE-A920-CE341126A6E6Q74234814-8D178CED-C46E-48A0-BA33-6878548B655BQ74319061-C98E6522-5DC2-436C-9011-8781FA428586Q74470349-8545CC36-EBF6-4E93-9EF5-C6318541AEC8
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
N Wedlock
@ast
N Wedlock
@en
N Wedlock
@es
N Wedlock
@nl
type
label
N Wedlock
@ast
N Wedlock
@en
N Wedlock
@es
N Wedlock
@nl
prefLabel
N Wedlock
@ast
N Wedlock
@en
N Wedlock
@es
N Wedlock
@nl
P31
P496
0000-0003-0845-8641